ArticleFrontiers in cellular and infection microbiology2025
The diagnostic value of RNA-mNGS and DNA-mNGS in differentiating bacterial infection from colonization in the lower respiratory tract.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Pathogens and clinical characteristics of type 2 diabetes mellitus in patients with community-acquired pneumonia via bronchoalveolar lavage fluid (BALF) metagenomic next-generation sequencing: a comparative observational study.Journal of thoracic disease · 2026Article
- Case Report: Sequential mNGS captures fatal HSV-1 reactivation after intestinal obstruction-associated ARDS in a 91-year-old.Frontiers in medicine · 2026Article
- Next-generation sequencing in the etiological diagnosis of severe childhood pneumonia.Frontiers in pediatrics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Metagenomic next-generation sequencing(mNGS) has been widely used in the pathogenetic diagnosis of lower respiratory tract infections. However, the interpretation of pathogens detected by mNGS remains inconclusive. Objective: Our study aimed to compare the differential diagnostic value of sequencing reads and the relative abundance of bacteria detected by RNA-mNGS versus DNA-mNGS in distinguishing between bacterial infection and colonization in the lower respiratory tract. Methods: The hospitalized patients with suspected lower respiratory tract infections who had completed RNA-mNGS and DNA-mNGS testing at our hospital from June 2021 to December 2023 were reviewed and divided into two groups: the infected group and the colonized group, based on their final diagnoses. The Mann-Whitney U test was used to analyze differences in the number of bacterial sequencing reads and relative abundance between the two groups; the predictive capability of bacterial sequencing reads and relative abundance for identifying bacterial infections was evaluated using receiver operating characteristic (ROC) curves. Results: A total of 69 eligible patients were enrolled, with 85 detections of the four target bacterial species ( Conclusions: Bacterial relative abundance and sequencing reads can serve as indicators to distinguish between infection and colonization, and the relative abundance based on RNA-mNGS exhibits the best differential diagnostic performance; when DNA-mNGS results stand alone, the relative abundance of the detected bacteria and the ratio of relative abundance between the first-ranked and the second-ranked detected bacteria can be utilized for a comprehensive assessment of infection versus colonization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.